Published online Jun 30, 2008.
https://doi.org/10.4111/kju.2008.49.6.490
The Analysis of Prognostic Factors of Survival for Patients with Renal Cell Carcinoma according to Lymph Node Involvement or Metastasis
Abstract
Purpose
The prognostic factors of renal cell carcinoma (RCC) are well known. However, the knowledge about the behavior of the nodal and metastatic involvement is still lacking. We analyzed the prognostic factors and survival for patients with various statuses of RCCs.
Materials and Methods
We conducted a retrospective review of 1,140 patients who had RCC between 1989 and 2005. The patients with multifocal and/or cystic RCCs, bilateral RCCs, RCCs related to ESRD and von Hippel-Lindau disease or the patients who didn't undergo lymph node dissection were excluded. The patients were divided into 4 groups; the TxN0M0 (473 patients), TxN1-2M0 (31), TxN0M1 (47) and TxN1-2M1 (21) groups. Univariate and multivariate analysis were performed to identify the prognostic factors (age, the mean tumor size, the pT stage, the histological type, the nuclear grade and the presence of symptoms). The five-year cancer-specific survival (CSS) also was calculated.
Results
The five-year CSS for each group was 90.5%, 62.8%, 38.8% and 17.9%, respectively. For the TxN0M0 group, every prognostic factor had a significant impact on survival on univariate analysis. Multivariate analysis subsequently showed that the pT stage, the histological type and the nuclear grade were independent prognostic factors. For the TxN1-2M0 group, the histological type was a significant prognostic factor. Age and the pT stage were independent prognostic factors for the TxN0M1 group and the presence of symptoms was an independent prognostic factor for the TxN1-2M1 group.
Conclusions
The survival was the highest for the TxN0M0 group and it was the lowest for the TxN1-2M1 group. The survival for the TxN1-2M0 group was better than that for the TxN0M1 group. These results obtained by analyzing the prognostic factors and the five-year CSS according to the various nodal and metastatic statuses of RCC patients will provided crucial information to predict clinical progression and the survival outcomes.
Fig. 1
Cancer-specific survival according to the lymph node involvement or metastasis (Kaplan-Meier cancer survival curve).
Table 1
Clinical characteristics
Table 2
Five-year cancer-specific survival for the patients with renal cell carcinoma according to lymph node involvement or metastasis
Table 3
Multivariate analysis of the five-year cancer-specific survival for patients with renal cell carcinoma without involvement of the lymph node or other organs (multivariate Cox regression model)
References
-
American Cancer Society. Cancer facts & figures 2007. Atlanta, GA: American Cancer Society; 2007.
-
-
Kim WJ, Chung JI, Hong JH, Kim CS, Jung SI, Yoon DK. Epidemiological study for urologic cancer in Korea (1998-2002). Korean J Urol 2004;45:1081–1088.
-
-
Ministry of Health and Welfare. 2002 Annual report of the Korea Central Cancer Registry. 2003.
-
-
Campbell SC, Novick AC, Bukowsik RM. Renal tumor. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelpia: Saunders; 2006. pp. 1603-1607.
-
-
Green FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. In: AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002. pp. 323-328.
-
-
Kim SW, Park WJ, Ha JS, Lee SJ, Lee JY, Lee CB, et al. Prognostic factors in renal cell carcinoma. Korean J Urol 2002;43:98–105.
-
-
Chang YS, Moon WC, Kim YS. Analysis of prognostic factors in renal cell carcinoma. Korean J Urol 1994;35:1065–1072.
-
-
Henson DE, Fielding LP, Grignon DJ, Page DL, Hammond ME, Nash G, et al. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee. Arch Pathol Lab Med 1995;119:1109–1112.
-
-
Kang JS, Kim JC, Rhew HY. Comparitive analysis of advanced renal cell carcinoma according invasion, metastatic sites and number. Korean J Urol 2000;41:725–730.
-